BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
-2.31%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.53B
AUM Growth
-$239M
(-14%)
Cap. Flow
-$3.25M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
79.89%
Holding
32
New
1
Increased
4
Reduced
–
Closed
2
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
+$11.5M |
| 2 |
Nautilus Biotechnolgy
NAUT
|
+$10.1M |
| 3 |
Dynavax Technologies
DVAX
|
+$8.63M |
| 4 |
PANA
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
|
+$5.01M |
| 5 |
Tango Therapeutics
TNGX
|
+$4.8M |
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$32.7M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
+$10.5M |
Sector Composition
| 1 | Healthcare | 88.31% |
| 2 | Financials | 2.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PANA
26
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $5.01M | 0.33% |
+500,000
| New | +$5.01M |
|
|
OMEG
27
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $3.98M | 0.26% |
400,000
| – | – |
|
|
FLACU
28
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
| $3.02M | 0.2% |
300,000
| – | – |
|
|
JYAC
29
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $2.98M | 0.2% |
300,000
| – | – |
|
30
MoonLake Immunotherapeutics
MLTX
$3.34B
| $2.59M | 0.17% |
250,000
| – | – |
|
|
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-1,000,000
| Closed | -$10.5M |
|
|
CNST
32
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-1,400,000
| Closed | -$32.7M |
|